UMIN-ICDS Clinical Trial

Unique ID issued by UMIN UMIN000054143
Receipt number R000061824
Scientific Title Clinical Study on the Efficacy of Tirzepatide for Diabetes Complicated Obesity
Date of disclosure of the study information 2024/04/13
Last modified on 2024/04/13 12:10:52

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical Study on the Efficacy of Tirzepatide for Diabetes Complicated Obesity

Acronym

Clinical Study on the Efficacy of Tirzepatide for Diabetes Complicated Obesity

Scientific Title

Clinical Study on the Efficacy of Tirzepatide for Diabetes Complicated Obesity

Scientific Title:Acronym

Clinical Study on the Efficacy of Tirzepatide for Diabetes Complicated Obesity

Region

Japan


Condition

Condition

Obesity with diabetes mellitus and BMI over 25

Classification by specialty

Medicine in general Endocrinology and Metabolism

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Observe the effectiveness of Tirzepatide

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Fat CT (Total fat amount, Visceral fat amount, Subcutaneous fat amount)

Key secondary outcomes

1) Body weight
2) BMI
3) BUN, Cr, eGFR
4) AST, ALT
5) T-cho, LDL, HDL, TG
6) Cystatin C
7)) Oxidized LDL, High-sensitivity CRP
8) NTProBNP
9) Fatty acid fraction
10) Albuminuria
11) Side effects


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

90 years-old >=

Gender

Male and Female

Key inclusion criteria

Obesity with diabetes mellitus and BMI over 25

Key exclusion criteria

Patients who were deemed not appropriate to participate in this study by doctor

Target sample size

10


Research contact person

Name of lead principal investigator

1st name Akira
Middle name
Last name Sezai

Organization

Nihon University School of Medicine

Division name

Department of Cardiovascular Surgery

Zip code

1738610

Address

30-1 Oyaguchi kami-machi, Itabashi-ku, Tokyo, Japan

TEL

03-3972-8111

Email

asezai.med@gmail.com


Public contact

Name of contact person

1st name Mitsue
Middle name
Last name Akiyama

Organization

Sekino Laboratory

Division name

Department of Research

Zip code

1710014

Address

3-28-3 Ikebukuro, Toshima-ku, Tokyo, Japan

TEL

03-3986-5501

Homepage URL


Email

skn-np@sekino-hospital.com


Sponsor or person

Institute

Sekino Hospital

Institute

Department

Personal name



Funding Source

Organization

self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Sekino Laboratory

Address

3-28-3 Ikebukuro, Toshima-ku, Tokyo, Japan

Tel

03-3986-5501

Email

skn-np@sekino-hospital.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

関野病院(東京都)


Other administrative information

Date of disclosure of the study information

2024 Year 04 Month 13 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2024 Year 02 Month 20 Day

Date of IRB

2024 Year 03 Month 12 Day

Anticipated trial start date

2024 Year 03 Month 19 Day

Last follow-up date

2025 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Observation for 12 months


Management information

Registered date

2024 Year 04 Month 13 Day

Last modified on

2024 Year 04 Month 13 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000061824


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name